v3.25.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Statement of Cash Flows [Abstract]    
Net Loss $ (13,818) $ (12,805)
Proceeds from issuance of ordinary shares, net of issuance costs 30,758
Proceeds from the conversion of convertible bonds 21,696
Proceeds from exercise of warrants 493
Proceeds from exercise of options 438
Net cash provided by financing activities 53,385
Adjustments to reconcile loss to net cash used in operating activities:    
Depreciation 135 142
Share-based compensation 3,310 3,726
Warrants to service providers 209 348
Revaluation of warrants (280) (112)
Revaluation of convertible bonds 27
Finance income (207)
Change in operating assets and liabilities:    
Decrease in trade receivable 93 402
Increase in prepaid expenses and other receivables 1,070 (172)
Operating lease ROU assets and liabilities, net 54 129
Increase (decrease) in trade payables (70) 517
Increase in employees and payroll accruals (3) 145
Increase (decrease) in Derivative Liabilities 1,712
Increase (decrease) in accrued expenses and other payables 1,546 (695)
Net cash used in operating activities (6,222) (8,376)
Cash flows from investing activities:    
Change in bank deposits (53,180) (14,902)
Purchase of property and equipment (25) (81)
Net cash provided by (used in) investing activities (53,205) (14,983)
Cash flows from financing activities:    
Net Loss (13,818) (12,805)
Proceeds from issuance of ordinary shares, net of issuance costs 30,758
Proceeds from the conversion of convertible bonds 21,696
Proceeds from exercise of warrants 493
Proceeds from exercise of options 438
Net cash provided by financing activities 53,385
Effect of exchange rate fluctuations on cash and cash equivalent (542) 256
Increase (decrease) in cash, cash equivalents and restricted cash (6,042) (23,615)
Cash, cash equivalents and restricted cash at the beginning of period 13,768 28,750
Cash, cash equivalents and restricted cash at the end of period $ 7,184 $ 5,391